Oliclinomel N6-900e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The blend delivers essential amino acids directly into the bloodstream, bypassing the digestive system. These amino acids act as building blocks for new proteins, replenish nitrogen stores, and serve as precursors for various metabolic pathways, helping to maintain muscle mass, support wound healing, and provide energy substrates during periods of catabolic stress.

The dose of Oliclinomel N6-900e is individualized and determined by the prescribing clinician based on the patient’s weight, clinical condition, renal and hepatic function, and overall nutritional goals. No fixed dosing regimen is provided in public literature; the healthcare professional calculates the appropriate infusion rate and duration.

Safety data for Oliclinomel N6-900e in pregnancy and lactation are limited. Because the product supplies essential amino acids, it may be considered when the benefits outweigh potential risks, but clinicians should evaluate each case carefully and discuss possible implications with the patient.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, requesting trade or institutional credentials. The sales team will respond with pricing, availability, shipping details (including cold‑chain if needed), and any required import documentation.

Oliclinomel N6-900e offers a balanced profile of ten essential amino acids, similar to other commercial amino acid solutions. Its formulation complies with EU quality standards and is intended for prescription use. Compared with some alternatives that may contain additional non‑essential amino acids or higher concentrations, Oliclinomel provides a standard essential amino acid mix suitable for most parenteral nutrition protocols.

The product must be stored refrigerated at 2‑8 °C. It should be kept in its original container, protected from light, and must not be frozen or shaken. Before use, inspect the solution for any particulate matter or discoloration and allow it to reach room temperature if required by the infusion protocol.

Oliclinomel N6-900e is administered intravenously, typically as a continuous infusion or intermittent infusion according to the clinician’s prescription. The solution is added to a compatible IV bag or administered via a dedicated infusion set, and infusion rates are adjusted based on the patient’s metabolic needs and laboratory monitoring.

The most serious risks include severe allergic reactions such as anaphylaxis, significant electrolyte disturbances (e.g., hyperkalemia, hypocalcemia), and acute renal dysfunction in patients with pre‑existing kidney disease. Prompt recognition and management of these events are essential, and patients should be monitored closely during and after the infusion.

Oliclinomel N6-900e should be avoided in patients with known hypersensitivity to any of its amino acid components, in those with uncontrolled severe electrolyte imbalances, and in individuals with severe hepatic or renal failure where amino acid overload could exacerbate organ dysfunction. Contraindications are determined by the prescribing physician based on clinical assessment.